Our aim was to compare racial/ethnic as well as regional patterns in the cardiovascular and renal effectiveness and safety of SGLT2-Is and GLP1-RAs in patients with T2D, using a systematic meta-analysis of CVOTs of SGLT2-I and GLP1-RA. Here, SLC5A2 is linked to type 2 diabetes mellitus.